Pathogenic Cell in COPD: Mechanisms of Airway Remodeling, Immune Dysregulation, and Therapeutic Implications
- PMID: 40860610
- PMCID: PMC12377387
- DOI: 10.2147/COPD.S523519
Pathogenic Cell in COPD: Mechanisms of Airway Remodeling, Immune Dysregulation, and Therapeutic Implications
Abstract
The pathological alterations in COPD cells represent adaptive responses to COPD lesions, focusing on three primary pathological changes: abnormal repair and tissue remodeling, protease-antiprotease imbalance, and inflammatory amplification alongside immune disorder. These alterations ultimately result in a detrimental cycle of lung parenchymal destruction and airway structural remodeling. COPD manifests with diverse pathological phenotypes, pronounced heterogeneity, and a convoluted evolution process. However the role of pathological changes and mechanisms in pathological cells, as well as cellular senescence, metabolic reprogramming, and intercellular interaction networks in COPD, remains unclear. This review comprehensively encapsulates the most recent research advancements regarding the principal pathological cells in COPD, encompassing airway epithelial cells, fibroblasts, endothelial cells, and immune inflammatory cells. Elucidated the pathological alterations of these cells in relation to COPD, their influence on disease progression, and their clinical implications. Furthermore, Exosome-mediated miRNA transfer exacerbates inflammation and fibrosis, suggesting novel therapeutic targets. In summary, our work aims to provide a basic reference for research into the pathogenic mechanisms of this disease.
Keywords: NETosis; airway epithelial cells; cellular senescence; chronic obstructive pulmonary disease; endothelial cells; extracellular vesicles; fibroblasts; immune inflammatory cells; miRNA.
© 2025 Zhou et al.
Conflict of interest statement
The authors declare that they have no competing interests in this work.
Figures
Similar articles
-
Chronic Obstructive Pulmonary Disease Airway Epithelial Cell-derived Extracellular Vesicles Spread Cellular Senescence via MicroRNA-34a.Am J Respir Cell Mol Biol. 2025 Aug;73(2):210-220. doi: 10.1165/rcmb.2024-0183OC. Am J Respir Cell Mol Biol. 2025. PMID: 39836066 Free PMC article.
-
Cigarette Smoke Extract-Induced Necroptosis Causes Mitochondrial DNA Release and Inflammation of Bronchial Epithelial Cells.Int J Chron Obstruct Pulmon Dis. 2025 Aug 1;20:2685-2695. doi: 10.2147/COPD.S523610. eCollection 2025. Int J Chron Obstruct Pulmon Dis. 2025. PMID: 40765678 Free PMC article.
-
Sirtuin 3 deficiency exacerbates emphysema and lung inflammation in a murine model of chronic obstructive pulmonary disease.Am J Physiol Lung Cell Mol Physiol. 2025 Aug 1;329(2):L200-L213. doi: 10.1152/ajplung.00212.2024. Epub 2025 Jun 25. Am J Physiol Lung Cell Mol Physiol. 2025. PMID: 40560598
-
A review of research advances in the modulation of olfactory receptors for COPD inflammation and airway remodeling.Front Immunol. 2025 Jul 4;16:1612165. doi: 10.3389/fimmu.2025.1612165. eCollection 2025. Front Immunol. 2025. PMID: 40688081 Free PMC article. Review.
-
p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics.Cell Commun Signal. 2023 Nov 2;21(1):314. doi: 10.1186/s12964-023-01337-4. Cell Commun Signal. 2023. PMID: 37919729 Free PMC article.
References
-
- Halpin DMG, Criner GJ, Papi A, et al. Global Initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203(1):24–36. doi: 10.1164/rccm.202009-3533SO - DOI - PMC - PubMed
-
- 9789240084452-eng.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical